Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Campone

Showing results (11-20 of 302) with videos related to

Pageof 31
Sort By:
Nature Reviews. Cancer|June 21, 2013
Decoding and unlocking the BCL-2 dependency of cancer cellsPhilippe Juin, Olivier Geneste, Fabien Gautier, et al.
Critical Reviews in Oncology/Hematology|July 26, 2005
Taxanes in adjuvant breast cancer setting: which standard in Europe?Mario Campone, Pierre Fumoleau, Emmanuelle Bourbouloux, et al.
Expert Opinion on Investigational Drugs|September 28, 2005
Vinflunine: a novel antitubulin agent in solid malignanciesJaafar Bennouna, Mario Campone, Jean Pierre Delord, et al.
Veterinary Pathology|May 23, 2019
Feline Invasive Mammary Carcinomas: Prognostic Value of Histological GradingElie Dagher, Jérôme Abadie, Delphine Loussouarn, et al.
Therapeutic Advances in Medical Oncology|August 13, 2020
Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancerPauline du Rusquec, Cyriac Blonz, Jean Sebastien Frenel, et al.
Bioinformatics (Oxford, England)|May 19, 2025
HABiC: an algorithm based on the exact computation of the Kantorovich-Rubinstein optimizer for binary classification in transcriptomicsChiara Cordier, Pascal Jézéquel, Mario Campone, et al.
Bulletin Du Cancer|October 19, 2020
[Genetic instability, a factor limiting the efficiency of targeted therapies in solid oncology]Amandine Billaud, Louise-Marie Chevalier, Mario Campone, et al.
Cancer Treatment Reviews|April 6, 2013
mTOR inhibitors in advanced breast cancer: ready for prime time?Lesley-Ann Martin, Fabrice André, Mario Campone, et al.
Bulletin Du Cancer|May 23, 2012
[Tumor resistance to HER2 inhibitors: the drug sedimentation concept]Mario Campone, Jean-Sébastien Frenel, Fabrice André, et al.
BMC Veterinary Research|January 12, 2019
Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational studyElie Dagher, Jérôme Abadie, Delphine Loussouarn, et al.
Pageof 31

Showing results (11-20 of 302) with videos related to

Sort By:
Pageof 31
Nature Reviews. Cancer|June 21, 2013
Decoding and unlocking the BCL-2 dependency of cancer cellsPhilippe Juin, Olivier Geneste, Fabien Gautier, et al.
Critical Reviews in Oncology/Hematology|July 26, 2005
Taxanes in adjuvant breast cancer setting: which standard in Europe?Mario Campone, Pierre Fumoleau, Emmanuelle Bourbouloux, et al.
Expert Opinion on Investigational Drugs|September 28, 2005
Vinflunine: a novel antitubulin agent in solid malignanciesJaafar Bennouna, Mario Campone, Jean Pierre Delord, et al.
Veterinary Pathology|May 23, 2019
Feline Invasive Mammary Carcinomas: Prognostic Value of Histological GradingElie Dagher, Jérôme Abadie, Delphine Loussouarn, et al.
Therapeutic Advances in Medical Oncology|August 13, 2020
Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancerPauline du Rusquec, Cyriac Blonz, Jean Sebastien Frenel, et al.
Bioinformatics (Oxford, England)|May 19, 2025
HABiC: an algorithm based on the exact computation of the Kantorovich-Rubinstein optimizer for binary classification in transcriptomicsChiara Cordier, Pascal Jézéquel, Mario Campone, et al.
Bulletin Du Cancer|October 19, 2020
[Genetic instability, a factor limiting the efficiency of targeted therapies in solid oncology]Amandine Billaud, Louise-Marie Chevalier, Mario Campone, et al.
Cancer Treatment Reviews|April 6, 2013
mTOR inhibitors in advanced breast cancer: ready for prime time?Lesley-Ann Martin, Fabrice André, Mario Campone, et al.
Bulletin Du Cancer|May 23, 2012
[Tumor resistance to HER2 inhibitors: the drug sedimentation concept]Mario Campone, Jean-Sébastien Frenel, Fabrice André, et al.
BMC Veterinary Research|January 12, 2019
Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational studyElie Dagher, Jérôme Abadie, Delphine Loussouarn, et al.
Pageof 31